TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, f ...

Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...

Roche will be the first to join Harvard's Enterprise Research Campus in Allston, taking a suite in the first phase of the ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...

The U.S. Food and Drug Administration has approved TNKase ... as an intravenous bolus followed by a 60-minute infusion. Genentech, the manufacturer of TNKase, says a new 25-mg vial configuration ...

THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ... bolus followed by a 60-minute infusion. Genentech, the manufacturer of TNKase, says a new 25 ...

It will also support some of Roche’s and Genentech’s efforts in AI and data science to accelerate drug discovery and development. The laboratories will be equipped for advanced research, and over time ...